chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lip started getting tingly and swelling, only on the top left side; lip started getting tingly and swelling, only on the top left side; sore arm; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 25-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6208), via intramuscularly in Arm Left on 11Mar2021 at around 16:30-16:35 (at the age of 25-Years-old) as single dose for COVID-19 immunisation. The patient's medical history was reported as none. There were no concomitant medications. Previously, the patient received first dose of Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was reported as None. Additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as No. Prior Vaccinations (within 4 weeks) was reported as No. Relevant tests were reported as none. On 11Mar2021, the patient experienced sore arm. She stated after receiving the vaccine, she got just a regular sore arm. She explained the sore arm started that night after receiving the vaccine and lasted for about 2 days. After about 2 days, she did not have it anymore. On 15Mar2021, lip started getting tingly and swelling, only on the top left side. She noticed that her lip started getting tingly and it started swelling, only on the top left side. She stated it feels like the swelling has went down a little bit. She does not know if this came from the vaccine or if it was an allergic reaction. She was not sure. At the time of this report, the outcome of sore arm was reported as recovered on 13Mar2021 and another event was recovering  No follow-up attempts are possible. No further information is expected.
Very mild Sore arm after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very mild Sore arm after second shot) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced PAIN IN EXTREMITY (Very mild Sore arm after second shot). On 15-May-2021, PAIN IN EXTREMITY (Very mild Sore arm after second shot) had resolved.            No relevant concomitant medication was reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-395855, MOD-2021-396448 (Patient Link).
Patient reports hive on entire body and very swollen face and lips that started day after receiving vaccine.
Patient experienced hives on face/neck after first Moderna dose in Feb, treated w/ benadryl at that time, lasted several hours, no mouth/throat swelling. Patient was scheduled for his 2nd Moderna dose at clinic. Given his reaction to moderna previously he was sent to outpatient pharmacy to get Janssen (J&J) vaccine. After the Janssen Covid vaccine was administered patient immediately began feeling red, hot, and itchy. Was given benadryl 25mg/5ml oral dose x2 after being monitored for 30 min. Told patient if symptoms got worse or persisted to come back to hospital. After monitoring patient he felt safe to go home and had no visible signs of reaction after 30 min. Called patient to follow up 24 hours later and he stated he felt a "little itchy" that evening and had flu like symptoms when he woke up in the morning (achy, chills) but the itching went away last night.
Information has been received from a certified medical assistant concerning a 69 year old male with hypertension and high cholesterol, who on 28-AUG-2007 was vaccinated with a 0.5mL dose of PNEUMOVAX (Lot# 658074/0961U).  Subsequently, soon after receiving the vaccination the patient experienced fatigue, followed by a delayed onset of left arm pain, swelling and redness from elbow to shoulder.  At the time of the report, the patient's outcome was unknown.  This report is one report of three provided by the same source.  Additional information has been requested.
summons to vehicle for c/o.   " slight throat tightness"  She reports is most likely.  R/T Anxiety.  Resolved with removal of mask, fresh air & emotional support.   BP 118/76 - P 55;  16 Resp unablored.  Symptom resolved within 3 mins. time.
This spontaneous report was received from a medical assistant refers to a patient of unknown demographics. The patient's medical history, concurrent conditions, concomitant medications, and drug interactions/allergies were unknown. On 29-NOV-2018, the patient was vaccinated with expired (Expired product administered) VAQTA lot # N02699, Expiry: 10-NOV-2018, 1 dose (frequency and route of administration unknown) for prophylaxis. No adverse effect reported. No product quality complaint was involved.
Received Prevnar on 4/12/02 and 7/31/02. Per parents (infant not seen) developed "high fever" reported 103 and vomiting x 7 days because of initial fever and vomiting w/ 1st dose (given w/DTaP, IPV and HIB). Given 2nd dose with IPV only.
Information has been received from a 24 year old female patient, for GARDASIL vaccine, a Pregnancy Registry product concerning herself with no pertinent medical history and no known drug allergy who in September 2008, was vaccinated with the second dose of GARDASIL vaccine. Concomitant therapy included INFLUENZA VIRUS vaccine (unspecified). In approximately 06-DEC-2008 ("a month ago"), the patient was pregnant. LMP was approximately 06-DEC-2008 and estimated delivery date was 12-Sep-2009. The patient also experienced feeling nauseous and headache. Therapy with GARDASIL vaccine was discontinued. No lab diagnostics studies were performed. The patient did not seek medical attention. At the time of reporting, the patient did not recover yet. No further information is available.
Upper body hives, Low grade fever 99.6, dizziness, weakness, tiredness, upper body muscle pain, nausea.  All lasting 24 hours+.
Had Varivax shot on 2/3/06.  Diagnosis: with chicken pox on 9/27/06
Patient said she had soreness following vaccine but within a few days she developed more of a rash. It was red from shoulder to elbow with red bumps,
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2022 at 3:09 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Jan-2022 at 3:09 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Patient ethnicity reported.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported by reporter.
Diarrhea; Chills; Vomiting; Pain/Ache; This is a spontaneous report from a contactable consumer (the patient).  A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in Mar 2021 (on Friday as reported) as unknown,0.3ml single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date,the patient experienced diarrhea, chills, vomiting , pain, ache. The patient stated that he got some pretty bad symptoms.Consumer stated that he did not get it from the hospital.No Lab work was done.Therapeutic measures were taken as a result of diarrhea and included treatment with Imodium. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
Dizziness, Headache, Myalgia, CoughWheeze, self report temp: 100.9 on 12/29; ~99.0 on 12/30 Narrative:
1st dose on 2018 and is late for 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 24th September 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 3-Aug-2022 Reporter's comment: A pharmacist reported that the patient was late for 2nd dose of Shingrix. The reporter did not had the lot/ expiry date. The reporter consented to follow-up via email. Additional supportive information: Till the time reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Neuropathy, burning in arms and legs, tingling in hands and feet, numbing in extremities, pain in heart, severe body aches that start 6 days after second dose of vaccine and is still occurring 6 weeks later.
On day 8 after vaccination, my injection site in the left deltoid swelled & became painful. On day 9 the pain was better but the injection site became erythematous over the whole deltoid area. On day 10 (today) the erythema spread down my left anterior upper arm and the areas with erythema were mildly swollen & tender. It is not itchy.  Sorry for the big words, I am a physician
Yellowish bruise towards the back of her left arm; Blistery rash; Cannot move left arm/Restricted to do normal activities; Terrible pain on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Cannot move left arm/Restricted to do normal activities), VACCINATION SITE BRUISING (Yellowish bruise towards the back of her left arm), VACCINATION SITE PAIN (Terrible pain on her left arm) and VACCINATION SITE URTICARIA (Blistery rash) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced MOBILITY DECREASED (Cannot move left arm/Restricted to do normal activities) (seriousness criterion disability) and VACCINATION SITE PAIN (Terrible pain on her left arm) (seriousness criterion disability). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Yellowish bruise towards the back of her left arm) (seriousness criterion disability) and VACCINATION SITE URTICARIA (Blistery rash) (seriousness criterion disability). On 05-Apr-2021, VACCINATION SITE BRUISING (Yellowish bruise towards the back of her left arm) had resolved. On 06-Apr-2021, VACCINATION SITE URTICARIA (Blistery rash) had resolved. On 27-Apr-2021, MOBILITY DECREASED (Cannot move left arm/Restricted to do normal activities) and VACCINATION SITE PAIN (Terrible pain on her left arm) had resolved.            Treatment information included ibuprofen, paracetamol and also applied ice and heat for the event "terrible pain on her left arm". No concomitant medication was provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Non-significant follow up was accepted on 20-May-2021, address of reporter and last name of reporter were updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date the patient was administered with an improperly stored dose of ROTATEQ oral solution (strength, dose, dose number, lot number and expiration date were unspecified). No concomitant therapies were reported. No adverse events were reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I went in for a blood panel and the results showed Hyperthyroidism. I was referred to an endocrinologist. I have a family history of Hypothyroidism. When I was retested, it showed up as Hypothyroidism. They think it showed up as Hyperthyroidism at first because it was just overreacting. I am not on medication yet.
Tightness in chest, short of breath.  Assessment VS  B/P 142/78, HR 62, O2 Sat 100%.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium
This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of improperly stored VARIVAX lot # M043582, expiration date 28-OCT-2018 for prophylaxis. Concomitant therapies included sterile diluent. The excursion under temperature 15 to 46 degree Fahrenheit for 5 hours. The previously excursion was 15 to 46 degree Fahrenheit for 6 hours. Digital data logger was involved. No adverse events reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1708USA000559.
Patient received his second dose of the Pfizer vaccine in his left deltoid. After waiting approx. 10 min in the observation period post vaccine administration, patient verbalized that his "throat is closing". Upon looking in patients throat, no swelling, closure nor redness was noticed. Patient stated he had the same response to his first vaccine but did not receive any medication for his first dose as he left the clinic. Vital signs taken with Sp02 96% on RA. Water was given to patient and was able to drink well with no difficulty swallowing. Patient verbalized no SOB. Patient verbalized itching in throat with dry cough noted. Diphenhydramine 50mg administered orally for patient. Patient preferred oral administration instead of injection and stated he has taken benadryl in the past. After drinking water, patient stating starting to feel better. Patient then left clinic on his own accompanied by his wife and children. Patient was advised to seek medical care/ urgent care if symptoms worsen or new worsening symptoms arise.
Woke up feeling nausous, vertigo, dizzy and could not hear out right ear.  Used over the counter ear drops with no relief.  On 11/6/2010 went to a walk in medical clinic.  Was disgnosed with severe sinus infection and given mucinex, antibiotic and tramadol shot for pain.  On 11/9/10 was family doctor.  He also diagnosed a sinus infection and got another pain shot.  On 11/11/10 went to see an ENT specialist.  He diagnosed a viral infection and prescribed predinsone and famcicolzor.  11/22/10 saw family doctor and diagnosed total right hearing loss.  11/30/10 patient started taking pseudophed.  Quit the next day due to excessive nasal dryness.  Then 11/22/10 was told to order tinnitis formula.  Started taking medication on 12/1/10.  On 12/7/10 was ENT again and he told her that it would just take time to regain hearing.  Next appointment is scheduled for 5/4/2011.
This spontaneous report was received from a medical assistant and refers to a 15 month old patient of unknown gender. The patient's medical history, concomitant medications, concurrent conditions and drug allergies were not reported. On unknown date in April 2017, the patient was vaccinated with one dose of PROQUAD (rHA), lot # M042498 with expiration date on 17-APR-2018 (strength, route and anatomical side of the injection were not reported) and one dose of VARIVAX lot # M039378 with expiration date on 20-SEP-2018 (strength, route and anatomical side of the injection were not reported) (Inappropriate schedule of vaccine administered). No adverse effects was reported.
Twelve hours after receiving the second dose of vaccine (right arm with a significant swelling and redness, which I did not experience with the first shot), I had chills, a headache (no fever) and then sudden tremors all over my body with uncontrollable movements of my arms and legs (like convulsions). I felt like an electrical current was passing through my body  and my head, with  symptoms like obstetrician's hand, numbness of the mouth, and warmth in my head and body with headaches and a very stiff neck, tightness in my chest and back pain (mid and lower back alternatively). These symptoms lasted for months, but started to diminish about 2 months ago. I still have once in a while tingling in my hands and numbing/pain in lower back.
Received the following symptoms starting 15 hours after the vaccine.  Full body fatigue. Could not stand up for two hours from my bed. This was followed by body aches pains and chills. It also included heightened skin sensitivity. Physical touch and contact on anywhere but my palms in the pads of my feet was extremely painful. The best example I can give is, taking a shower was like getting shot at by multiple BB gun pellets.   At 1450 PST, I experience shortness of breath and wheezing. Struggled to walk up 12 steps.  Continued with migraine. Weakness in body. Pain and body. Skin sensitive until about 36 hours after the vaccine. Did not try walking up and down stairs again, but breathing was slightly challenged Until about 30 hour mark.  Struggled with migraines from The 24 hour mark until the 48 hour mark.It was the weekend. I did not go in. I just graded it out. Fatigue lasted all the way until the 48 hour mark.  Funny enough? I did not developed a sore arm symptom.
This spontaneous report was received from a medical assistant refers to unspecified 13 patients of unknown age and gender. This report pertains to the patient who on 01-OCT-2013 was vaccinated with VARIVAX (Merck), (lot # J003540, expiry date 25-MAR-2015) 0.5 milliliter (ml), subcutaneous. The medical assistant reported that improperly stored VARIVAX (Merck) that was exposed to unsupported temperature conditions was administered to an unspecified patient. No adverse effect reported. No further information was available. This case is linked to 1312USA007815, 1312USA009865, 1312USA009866, 1312USA009867, 1312USA009868, 1312USA009869, 1312USA009870, 1312USA009871, 1312USA009873, 1312USA009874, 1312USA009875 (Same reporter link). Additional information has been requested.
Information has been received from a physician concerning a female who was vaccinated with a  dose of GARDASIL (lot # not available) "in arm". Subsequently, "the patient experienced pain and tenderness at injection site after receiving a dose of GARDASIL. These symptoms persisted for 6 weeks", and then the patient had recovered. There were no labs and diagnostic tests performed. The patient had sought medical attention. Follow-up information has been received concerning the 23 year old patient (weighing 100 pounds and height reported as "5'00") who on 06-MAY-2009 at 08:12 am, was vaccinated with her first dose of GARDASIL (lot # 1423X) in the left deltoid. At 8:55 AM on 06-MAY-2009, the patient started sweating then said "I feel like I am going to pass out". The physician was called and the patient was laid down on the examination table. Blood pressure was monitored and patient was fine after thirty minutes. She came back on 10-JUN-2009 complaining of arm hurting at left deltoid vaccination area. At the time of the report, the patient's status was unknown. No further information is available.
It started around 10 PM, he stated with 102 degree fever, body aches, fatigue and he couldn't even get out of the bed. He was really weak and extremely tired. These symptoms last thur 06/04/2021 and his fever broke. I thought we was out of the woods. Saturday, Jun 05, 2021 he woke up with severe chest pains. He had an irregular heartbeat and rapid heart beat. He fever was back and it was 100.8.  I called his PCP  and he said to take him to the ER.
Blood pressure just goes through the roof, up over 200; had a really terrible reaction to a booster shot; had a really terrible reaction to a booster shot; This is a spontaneous report from a contactable consumer (patient's spouse). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), first dose on unknown date for COVID-19 immunization and second dose on unknown date (8 months ago) for COVID-19 immunization and experienced blood pressure just goes through the roof, up over 200. It was reported that the patient had a really terrible reaction to a booster shot on an unspecified date, the Pfizer booster and reported that she had the same reaction from the second shot, eight months ago and her blood pressure just goes through the roof, up over 200. It was wondered if anybody else reported that and asked for recommendation on how to neutralize it. Stated that the patient was having a 'crisis' during the report and she might have to be taken back to the emergency. The patient underwent lab tests and procedures which included blood pressure measurement: 200 on unspecified date, blood pressure just goes through the roof, up over 200. The outcome of the event blood pressure just goes through the roof, up over 200 was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.